Roberto Lacava

571 total citations
27 papers, 374 citations indexed

About

Roberto Lacava is a scholar working on Psychiatry and Mental health, Pharmacology and Neurology. According to data from OpenAlex, Roberto Lacava has authored 27 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 6 papers in Neurology. Recurrent topics in Roberto Lacava's work include Neurological Disorders and Treatments (6 papers), Neurological Disease Mechanisms and Treatments (4 papers) and Dementia and Cognitive Impairment Research (4 papers). Roberto Lacava is often cited by papers focused on Neurological Disorders and Treatments (6 papers), Neurological Disease Mechanisms and Treatments (4 papers) and Dementia and Cognitive Impairment Research (4 papers). Roberto Lacava collaborates with scholars based in Italy, Brazil and United States. Roberto Lacava's co-authors include Pietro Gareri, Antonino Maria Cotroneo, Alberto Castagna, Giovambattista De Sarro, Salvatore Putignano, Regina H. Macedo, Rafael Maia, Fausto Fantò, Alba Malara and Francesco Monteleone and has published in prestigious journals such as PLoS ONE, Journal of Alzheimer s Disease and Hormones and Behavior.

In The Last Decade

Roberto Lacava

26 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Lacava Italy 13 110 91 54 51 42 27 374
Lucía Pérez-Costillas Spain 11 131 1.2× 27 0.3× 107 2.0× 21 0.4× 41 1.0× 29 500
Caterina Formica Italy 10 55 0.5× 28 0.3× 59 1.1× 13 0.3× 15 0.4× 52 325
Jacoline Neuteboom Netherlands 6 41 0.4× 26 0.3× 36 0.7× 20 0.4× 68 1.6× 7 415
Fengjie Gao China 9 103 0.9× 15 0.2× 51 0.9× 22 0.4× 53 1.3× 25 364
Wendy Baer United States 8 83 0.8× 45 0.5× 95 1.8× 94 1.8× 36 0.9× 11 563
Shu‐xian Xu China 13 105 1.0× 57 0.6× 24 0.4× 52 1.0× 127 3.0× 36 641
Piotr Marcinowicz Poland 8 96 0.9× 39 0.4× 30 0.6× 31 0.6× 34 0.8× 12 384
Manuel Martín Carrasco Spain 9 226 2.1× 17 0.2× 51 0.9× 47 0.9× 49 1.2× 26 370
Carlos Tirado United States 9 60 0.5× 11 0.1× 32 0.6× 81 1.6× 20 0.5× 20 318
Kostas Siarkos Greece 9 194 1.8× 30 0.3× 37 0.7× 34 0.7× 76 1.8× 19 323

Countries citing papers authored by Roberto Lacava

Since Specialization
Citations

This map shows the geographic impact of Roberto Lacava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Lacava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Lacava more than expected).

Fields of papers citing papers by Roberto Lacava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Lacava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Lacava. The network helps show where Roberto Lacava may publish in the future.

Co-authorship network of co-authors of Roberto Lacava

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Lacava. A scholar is included among the top collaborators of Roberto Lacava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Lacava. Roberto Lacava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Castagna, Alberto, et al.. (2021). Correction to: The CITIMERIVA Study: CITIcoline plus MEmantine plus RIVAstigmine in Older Patients Affected with Alzheimer’s Disease. Clinical Drug Investigation. 41(4). 413–413. 1 indexed citations
3.
4.
Castagna, Alberto, et al.. (2021). The CITIMERIVA Study: CITIcoline plus MEmantina plus RIVAstigmine in Older Patients Affected with Alzheimer’s Disease. Clinical Drug Investigation. 41(2). 177–182. 6 indexed citations
5.
Fazio, Pasquale De, et al.. (2015). Depressive symptoms in caregivers of patients with dementia: demographic variables and burden. Clinical Interventions in Aging. 10. 1085–1085. 50 indexed citations
6.
Gareri, Pietro, Alberto Castagna, Antonino Maria Cotroneo, et al.. (2014). Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study. Journal of Alzheimer s Disease. 41(2). 633–640. 22 indexed citations
7.
Gareri, Pietro, Alberto Castagna, Roberto Lacava, et al.. (2014). P2‐086: CITICOLINE IN COGNITIVE IMPAIRMENT: AN OLD DRUG WITH NEW PERSPECTIVES. Alzheimer s & Dementia. 10(4S_Part_13). 1 indexed citations
8.
Gareri, Pietro, Antonino Maria Cotroneo, Alberto Castagna, et al.. (2013). Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clinical Interventions in Aging. 8. 131–131. 71 indexed citations
9.
Maia, Rafael, et al.. (2012). Social Environment Affects Acquisition and Color of Structural Nuptial Plumage in a Sexually Dimorphic Tropical Passerine. PLoS ONE. 7(10). e47501–e47501. 18 indexed citations
10.
Gareri, Pietro, et al.. (2011). Brugada syndrome (BS) and syncope: A complex therapeutic issue. Archives of Gerontology and Geriatrics. 55(3). 706–708. 1 indexed citations
11.
Lacava, Roberto, et al.. (2010). Social environment affects testosterone level in captive male blue–black grassquits. Hormones and Behavior. 59(1). 51–55. 20 indexed citations
12.
Gareri, Pietro, Roberto Lacava, Antonino Maria Cotroneo, et al.. (2009). VALPROATE-INDUCED DELIRIUM IN A DEMENTED PATIENT. Archives of Gerontology and Geriatrics. 49. 113–118. 6 indexed citations
13.
Imazio, Massimo, Antonino Maria Cotroneo, Alessandra Chinaglia, et al.. (2007). Management of heart failure in elderly people. International Journal of Clinical Practice. 62(2). 270–280. 12 indexed citations
14.
Gareri, Pietro, Pasquale De Fazio, Antonino Maria Cotroneo, et al.. (2007). Anticholinergic drug-induced delirium in an elderly alzheimer's dementia patient. Archives of Gerontology and Geriatrics. 44. 199–206. 16 indexed citations
15.
Cotroneo, Antonino Maria, et al.. (2007). Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people. Archives of Gerontology and Geriatrics. 44. 121–124. 16 indexed citations
16.
Gareri, Pietro, Luca Gallelli, Guido Ferreri Ibbadu, et al.. (2005). Melaena following Use of the Cholinesterase Inhibitor Rivastigmine. Clinical Drug Investigation. 25(3). 215–217. 12 indexed citations
17.
Cotroneo, Antonino Maria, et al.. (2004). USE OF ZOLPIDEM IN OVER 75-YEAR-OLD PATIENTS WITH SLEEP DISORDERS AND COMORBlDlTlES. Archives of Gerontology and Geriatrics. 38(9). 93–96. 27 indexed citations
18.
Gareri, Pietro, et al.. (2004). COMPARISON OF THE EFFICACY OF NEW AND CONVENTIONAL ANTIPSYCHOTIC DRUGS IN THE TREATMENT OF BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD). Archives of Gerontology and Geriatrics. 38(9). 207–215. 28 indexed citations
19.
Gareri, Pietro, Roberto Lacava, Martín Rossi, et al.. (1996). Hypertension in a group of centenarians. Archives of Gerontology and Geriatrics. 22. 373–376. 13 indexed citations
20.
Galasso, M., et al.. (1996). Multidimensional evaluation in a group of centenarians. Archives of Gerontology and Geriatrics. 22. 377–380. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucía Pérez-Costillas Breakdown of academic impact, for papers by Caterina Formica Breakdown of academic impact, for papers by Jacoline Neuteboom Breakdown of academic impact, for papers by Fengjie Gao Breakdown of academic impact, for papers by Wendy Baer Breakdown of academic impact, for papers by Shu‐xian Xu Breakdown of academic impact, for papers by Piotr Marcinowicz Breakdown of academic impact, for papers by Manuel Martín Carrasco Breakdown of academic impact, for papers by Carlos Tirado Breakdown of academic impact, for papers by Kostas Siarkos
Rankless by CCL
2026